bpc 157 banned in sports American ultrarunner Mike McKnight has publicly admitted to using BPC-157, a peptide under the World Anti-Doping Agency code, while trying to avoid back surgery. McKnight, a 200-mile specialist and coach based BPC-157: Why Women Are Asking

Symptoms vary widely depending on the location and severity of the herniation

Product Specifications 10mL per vial 0.9% benzyl alcohol (9mg/mL) Sterile water for injection Multi-use diluent for lyophilised peptides 4.57.0 Room temperature (15-30C), protect from freezing Research Use Only: These products are intended for laboratory research use only and are not approved for human consumption

Health status considerations: Generally healthy adults with physician clearance, individuals without contraindications (pregnancy, active malignancy, severe organ disease), those willing to commit to proper administration protocols and monitoring, and patients who understand the research-purposes-only status and informed consent requirements

an FDA advisory review is scheduled for July 2026, with agency staff already recommending against approval

Tirzepatide is a dual-agonist targeting GLP-1 and GIP receptors, while retatrutide is a triple-agonist that also activates the glucagon receptor